Non-current contingent consideration Contingent Consideration, Noncurrent, Fair Value Contingent Consideration, Noncurrent, Fair Value Accumulated Amortization Finite-Lived Intangible Assets, Accumulated Amortization Range [Domain] Statistical Measurement [Domain] On-X On X [Member] On-X [Member] Realized investment gains (losses) Realized Investment Gains (Losses) Award Timing Predetermined Award Timing Predetermined [Flag] Indefinite-lived Intangible Assets [Axis] Indefinite-Lived Intangible Assets [Axis] Asset Class [Axis] Asset Class [Axis] Entity File Number Entity File Number Additional Paid-In Capital Additional Paid-in Capital [Member] Tabular List, Table Tabular List [Table Text Block] Existing Term Loan Facility Existing Term Loan Facility [Member] Existing Term Loan Facility Per Clot Per Clot [Member] PerClot [Member] New Accounting Pronouncements New Accounting Pronouncements, Policy [Policy Text Block] SOFR Secured Overnight Financing Rate (SOFR) [Member] Schedule of Financial Instruments Measured at Fair Value Fair Value, by Balance Sheet Grouping [Table Text Block] Medical devices Medical Devices [Member] Medical Devices [Member] Trading Arrangements, by Individual Trading Arrangements, by Individual [Table] Basic (in usd per share) Basic income (loss) per common share (in usd per share) Earnings Per Share, Basic Adjustment to Compensation: Adjustment to Compensation [Axis] Named Executive Officers, Footnote Named Executive Officers, Footnote [Text Block] Accounts payable, accrued expenses, and other liabilities Increase (Decrease) in Accounts Payable and Accrued Liabilities Revenue Recognition Revenue from Contract with Customer [Text Block] Other intangibles, net Intangible Assets Other Than Acquired Technology [Member] Intangible Assets Other Than Acquired Technology [Member] Minimum amount of future consideration payment Securities Purchase Option Agreement, Option To Acquire Outstanding Securities, Range Of Outcomes, Value, Low Securities Purchase Option Agreement, Option To Acquire Outstanding Securities, Range Of Outcomes, Value, Low Measurement Input, Discount Rate Measurement Input, Discount Rate [Member] Schedule of Revenues, Cost of Products and Services, and Gross Margins for Operating Segments Schedule of Segment Reporting Information, by Segment [Table Text Block] Inventory Disclosure [Abstract] Inventory Disclosure [Abstract] Schedule of Indefinite-Lived Intangible Assets [Table] Intangible Asset, Indefinite-Lived [Table] Consignment inventory percentage Consignment Inventory Percentage Consignment inventory percentage. Employee stock purchase plan (in shares) Stock Issued During Period, Shares, Employee Stock Purchase Plans Measurement Input Type [Domain] Measurement Input Type [Domain] Adjustment to Compensation, Amount Adjustment to Compensation Amount Option to purchase outstanding securities Securities Purchase Option Agreement, Option To Acquire Oustanding Securities Securities Purchase Option Agreement, Option To Acquire Oustanding Securities, Amount Non-cash compensation Share-Based Payment Arrangement, Noncash Expense Indefinite-lived Intangible Assets [Line Items] Indefinite-Lived Intangible Assets [Line Items] Stock option Share-Based Payment Arrangement, Option [Member] Award Timing MNPI Disclosure Award Timing MNPI Disclosure [Text Block] Proceeds from sale of assets Proceeds from Sale of Productive Assets Variable Interest Entity, Primary Beneficiary Variable Interest Entity, Primary Beneficiary [Member] Procurement contracts and agreements Contractual Rights [Member] Total stockholders’ equity Beginning balance Ending balance Equity, Attributable to Parent Insider Trading Policies and Procedures [Line Items] Common stock, shares authorized (in shares) Common Stock, Shares Authorized Goodwill and Intangible Assets Disclosure [Abstract] Goodwill and Intangible Assets Disclosure [Abstract] Patents Patents [Member] Current assets: Assets, Current [Abstract] Total liabilities and stockholders’ equity Liabilities and Equity Foreign Currency Translation and Transactions Foreign Currency Transactions and Translations Policy [Policy Text Block] Write-down of inventories and deferred preservation costs Write-Down of Deferred Preservation Costs and Inventories Amounts of the current period expense charged to cost of products and preservation services for the purpose of reducing deferred preservation costs and inventory, respectively, to amounts that approximate their net realizable value. LIABILITIES AND STOCKHOLDERS’ EQUITY Liabilities and Equity [Abstract] Cover [Abstract] Cash equivalents Cash and Cash Equivalents, Fair Value Disclosure Sale of PerClot Disposal Groups, Including Discontinued Operations, Disclosure [Text Block] Maximum Maximum [Member] Weighted Average Useful Life (Years) Finite-Lived Intangible Asset, Useful Life Acquired technology, net Net Carrying Value Finite-Lived Intangible Assets, Net Term Loan Facility Term Loan Facility [Member] Term Loan Facility Non-PEO NEO Average Total Compensation Amount Non-PEO NEO Average Total Compensation Amount Debt Instrument [Line Items] Debt Instrument [Line Items] Schedule of Share-based Compensation Arrangements by Share-based Payment Award [Table] Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table] Treasury Stock Treasury Stock, Common [Member] Adjustment to Non-PEO NEO Compensation Footnote Adjustment to Non-PEO NEO Compensation Footnote [Text Block] Pay vs Performance Disclosure [Line Items] From First Quarter of Fiscal Year 2025 and Thereafter From First Quarter of Fiscal Year 2025 and Thereafter [Member] From First Quarter of Fiscal Year 2025 and Thereafter Foreign currency translation adjustments, net of tax Foreign currency translation adjustments gain (loss) Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Portion Attributable to Parent Forgone Recovery due to Disqualification of Tax Benefits, Amount Forgone Recovery due to Disqualification of Tax Benefits, Amount Non-Rule 10b5-1 Arrangement Terminated Non-Rule 10b5-1 Arrangement Terminated [Flag] Income (loss) before income taxes Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest Entity Shell Company Entity Shell Company Other long-term liabilities Other Liabilities, Noncurrent Schedule of Long-term Debt Instruments [Table] Schedule of Long-Term Debt Instruments [Table] Proceeds from issuance of debt Proceeds from Issuance of Debt Goodwill, impairment loss Goodwill, Impairment Loss Option to purchase outstanding securities Securities Purchase Option Agreement, Option To Acquire Outstanding Securities Securities Purchase Option Agreement, Option To Acquire Oustanding Securities, Amount Statement of Stockholders' Equity [Abstract] Statement of Stockholders' Equity [Abstract] Operating Segments Operating Segments [Member] Variable Interest Entity [Table] Variable Interest Entity [Table] Less: Current portion of long-term debt Long-Term Debt, Current Maturities Statement of Cash Flows [Abstract] Statement of Cash Flows [Abstract] Other intangibles, net Other Intangible Assets, Net Company Selected Measure Amount Company Selected Measure Amount Award Timing MNPI Considered Award Timing MNPI Considered [Flag] Line of Credit Facility [Table] Line of Credit Facility [Table] Comprehensive (loss) income Comprehensive Income (Loss), Net of Tax, Attributable to Parent Measurement Input Type [Axis] Measurement Input Type [Axis] Disposal Group Name [Domain] Disposal Group Name [Domain] Name Measure Name Secured Debt Secured Debt [Member] Current maturities of operating leases Operating Lease, Liability, Current Schedule of Reconciliation of Changes in Fair Value of Level 3 Liabilities Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation [Table Text Block] If Prepayment Occurs Prior to July 18, 2027 If Prepayment Occurs Prior To July 18, 2027 [Member] If Prepayment Occurs Prior To July 18, 2027 Artivion Inc. And Starch Medical Inc. Artivion Inc. And Starch Medical Inc. [Member] Artivion, Inc. And Starch Medical, Inc. [Member] Deferred tax liabilities, net Deferred Income Tax Liabilities, Net Document Fiscal Period Focus Document Fiscal Period Focus Award Timing Method Award Timing Method [Text Block] Award Type [Axis] Award Type [Axis] Aggregate grant date market value Share Based Compensation Arrangement By Share Based Payment Award Other Than Options, Grant Date Fair Value Market value of share based compensation arrangement by share based payment award other than options granted during the period. Total debt Long-term debt Long-Term Debt Legal Entity [Axis] Legal Entity [Axis] Total assets Assets Trading Symbol Trading Symbol Geographical [Domain] Geographical [Domain] Cash payment amount Interest Expense, Long-Term Debt Schedule of Carrying Values of Indefinite Lived Intangible Assets Schedule of Intangible Assets and Goodwill [Table Text Block] Equity compensation (in shares) Shares Issued, Shares, Share-Based Payment Arrangement, after Forfeiture Entity Address, City or Town Entity Address, City or Town Net cash flows from operating activities: Cash Provided by (Used in) Operating Activity, Including Discontinued Operation [Abstract] Effect of exchange rate changes on cash and cash equivalents Effect of Exchange Rate on Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Continuing Operation Inventories and Deferred Preservation Costs Inventory Disclosure [Text Block] Non-PEO NEO Average Compensation Actually Paid Amount Non-PEO NEO Average Compensation Actually Paid Amount Compensation Actually Paid vs. Other Measure Compensation Actually Paid vs. Other Measure [Text Block] Variable Interest Entity [Line Items] Variable Interest Entity [Line Items] Entity Emerging Growth Company Entity Emerging Growth Company Entity Common Stock, Shares Outstanding Entity Common Stock, Shares Outstanding Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year [Member] Less: Unamortized debt issuance costs Debt issuance costs, net Debt Issuance Costs, Net Level 2 Fair Value, Inputs, Level 2 [Member] Insider Trading Policies and Procedures Not Adopted Insider Trading Policies and Procedures Not Adopted [Text Block] Total indefinite-lived intangible assets Indefinite-Lived Intangible Assets (Excluding Goodwill) Business Combination [Domain] Business Combination [Domain] Beginning balance (in shares) Ending balance (in shares) Common Stock, Shares, Outstanding PEO PEO [Member] Schedule of Disaggregation of Revenue Disaggregation of Revenue [Table Text Block] Interest income Investment Income, Interest Domestic UNITED STATES Changes in operating assets and liabilities: Adjustment to Reconcile Net Income to Cash Provided by (Used in) Operating Activity, Increase (Decrease) in Operating Capital [Abstract] Term Loan Facilities Term Loan Facilities [Member] Term Loan Facilities Exercise of options Stock Issued During Period, Value, Stock Options Exercised Non-cash lease expense Noncash Lease Expense Noncash Lease Expense Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year [Member] Schedule of Product Information [Table] Nature of Operation, Product Information, Concentration of Risk [Table] Retained Deficit Retained Earnings [Member] Prepaid expenses and other Prepaid Expense and Other Assets, Current Effective interest rate Debt Instrument, Interest Rate, Effective Percentage Entity Address, Postal Zip Code Entity Address, Postal Zip Code Restatement Determination Date Restatement Determination Date Securities purchase option agreement Securities Purchase Option Agreement Securities Purchase Option Agreement Share-based Payment Arrangement [Abstract] Share-Based Payment Arrangement [Abstract] Cash and cash equivalents beginning of period Cash and cash equivalents end of period Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Continuing Operation Income Statement [Abstract] Income Statement [Abstract] Income tax benefit Income Tax Expense (Benefit) Credit facility margin Debt Instrument, Basis Spread on Variable Rate Taxes payable Taxes Payable, Current Balance as of December 31, 2025 Balance as of March 31, 2026 Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset Value Preferred stock, shares issued (in shares) Preferred Stock, Shares Issued Pension Adjustments Service Cost Pension Adjustments Service Cost [Member] Intercompany Loans Intercompany Loans [Member] Intercompany Loans Products and Services [Domain] Product and Service [Domain] Fair Value Hierarchy and NAV [Axis] Fair Value Hierarchy and NAV [Axis] Consignment inventory Other Inventory, Materials, Supplies and Merchandise under Consignment, Gross Restatement does not require Recovery Restatement Does Not Require Recovery [Text Block] Total liabilities Liabilities, Fair Value Disclosure Discontinued Operations and Disposal Groups [Abstract] Organization, Consolidation and Presentation of Financial Statements [Abstract] Organization, Consolidation and Presentation of Financial Statements [Abstract] Compensation Actually Paid vs. Company Selected Measure Compensation Actually Paid vs. Company Selected Measure [Text Block] City Area Code City Area Code Award Timing, How MNPI Considered Award Timing, How MNPI Considered [Text Block] All Trading Arrangements All Trading Arrangements [Member] Equity Awards Adjustments, Footnote Equity Awards Adjustments, Footnote [Text Block] Total Shareholder Return Vs Peer Group Total Shareholder Return Vs Peer Group [Text Block] Accrued expenses Accrued Liabilities, Current Commitments and Contingencies Disclosure [Abstract] Commitments and Contingencies Disclosure [Abstract] Net cash flows from investing activities: Cash Provided by (Used in) Investing Activity, Including Discontinued Operation [Abstract] Triggering Event [Axis] Triggering Event [Axis] Triggering Event Pay vs Performance Disclosure Pay vs Performance Disclosure [Table] Net cash flows provided by (used in) operating activities Cash Provided by (Used in) Operating Activity, Including Discontinued Operation Principal payments on short-term notes payable Repayments of Short-Term Debt Preferred stock, par value (in dollars per share) Preferred Stock, Par or Stated Value Per Share Subsequent Event Subsequent Event [Member] Goodwill Beginning balance Ending balance Goodwill Equity Valuation Assumption Difference, Footnote Equity Valuation Assumption Difference, Footnote [Text Block] PEO Total Compensation Amount PEO Total Compensation Amount Long-term Debt, Type [Axis] Long-Term Debt, Type [Axis] Money market funds Money Market Funds [Member] Weighted-average common shares outstanding: Weighted Average Number of Shares Outstanding, Basic [Abstract] Diluted income (loss) per common share Net Income (Loss) Available to Common Stockholders, Diluted [Abstract] Equity Components [Axis] Equity Components [Axis] International Non-US [Member] Convertible Debt [Member] Convertible Debt [Member] Non-Rule 10b5-1 Arrangement Adopted Non-Rule 10b5-1 Arrangement Adopted [Flag] Number of reportable segments Number of Reportable Segments Contingent consideration, measurement input Business Combination, Contingent Consideration, Liability, Measurement Input Other Performance Measure, Amount Other Performance Measure, Amount Inventory [Line Items] Inventory [Line Items] Entity Address, State or Province Entity Address, State or Province Deferred preservation costs Deferred Preservation Costs Donated human tissue is procured from deceased human donors by tissue banks and organ procurement organizations, which consign the tissue to the Company for processing, preservation, and distribution. By federal law, human tissues cannot be bought or sold, so the preservation process is a manufacturing process that is accounted for using the same principles as inventory costing. Preservation costs consist primarily of direct labor and materials and indirect costs which are stated at the lower of cost or market value on a first in, first out basis and are deferred until revenue is recognized upon shipment of the tissue to an implanting facility. Contingent liability payment Disposal Group, Including Discontinued Operation, Contingent Liability Payment Disposal Group, Including Discontinued Operation, Contingent Liability Payment Debt instrument, unused borrowing capacity, amount Debt Instrument, Unused Borrowing Capacity, Amount Loans at fair value Endospan Loans Loans Receivable, Fair Value Disclosure Total current liabilities Liabilities, Current Individual: Individual [Axis] Additional paid-in capital Additional Paid in Capital, Common Stock Entity [Domain] Entity [Domain] Securities purchase option agreement, expiration period Securites Purchase Option Agreement, Expiration Period Securites Purchase Option Agreement, Expiration Period Net cash flows used in investing activities Cash Provided by (Used in) Investing Activity, Including Discontinued Operation Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table [Member] Document Fiscal Year Focus Document Fiscal Year Focus Basis of Accounting Basis of Accounting, Policy [Policy Text Block] Operating lease right-of-use assets, net Operating Lease, Right-of-Use Asset Forgone Recovery, Explanation of Impracticability Forgone Recovery, Explanation of Impracticability [Text Block] Repayment of debt Repayments of Long-Term Debt Effective income tax rate expense Effective Income Tax Rate Reconciliation, Percent Entity Interactive Data Current Entity Interactive Data Current Maximum amount of future consideration payment Securities Purchase Option Agreement, Option To Acquire Outstanding Securities, Range Of Outcomes, Value, High Securities Purchase Option Agreement, Option To Acquire Outstanding Securities, Range Of Outcomes, Value, High Exercise of options (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period Debt instrument, extension period Debt Instrument, Extension Period Debt Instrument, Extension Period Business Combination, Contingent Consideration, Type [Axis] Business Combination, Contingent Consideration, Type [Axis] Segment Information Segment Reporting Disclosure [Text Block] Disaggregation of Revenue [Table] Disaggregation of Revenue [Table] Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items] Commitment fee percentage Debt Instrument, Unused Capacity, Commitment Fee Percentage Debt Instrument, Unused Capacity, Commitment Fee Percentage Increase (Decrease) in Stockholders' Equity [Roll Forward] Increase (Decrease) in Stockholders' Equity [Roll Forward] Finite-Lived Intangible Assets [Line Items] Finite-Lived Intangible Assets [Line Items] Triggering Event [Domain] Triggering Event [Domain] Triggering Event [Domain] Compensation Actually Paid vs. Total Shareholder Return Compensation Actually Paid vs. Total Shareholder Return [Text Block] Business combination, contingent consideration, liability Business Combination, Contingent Consideration, Liability Fair Value, Recurring and Nonrecurring [Table] Fair Value, Recurring and Nonrecurring [Table] Amortization expense Amortization of Intangible Assets General, administrative, and marketing Selling, General and Administrative Expense Deferred tax assets, net Deferred Income Tax Assets, Net Depreciation and amortization Depreciation, Depletion and Amortization Notes receivable balance Financing Receivable, after Allowance for Credit Loss, Noncurrent Other long-term assets Other Assets, Noncurrent Conversion ratio Debt Instrument, Convertible, Conversion Ratio Accrued interest Interest Payable, Current Entity Central Index Key Entity Central Index Key PEO Name PEO Name Conversion price (in dollars per share) Debt Instrument, Convertible, Conversion Price Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year [Member] Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] Outstanding Aggregate Erroneous Compensation Amount Outstanding Aggregate Erroneous Compensation Amount Revolving Credit Facility Revolving Credit Facility [Member] Balance as of December 31, 2025 Balance as of March 31, 2026 Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value Non-current contingent consideration Business Combination, Contingent Consideration, Liability, Noncurrent Arrangement Duration Trading Arrangement Duration Schedule of Segment Reporting Information, by Segment [Table] Schedule of Segment Reporting Information, by Segment [Table] Ascyrus Medical LLC Ascyrus Medical Llc [Member] Ascyrus Medical LLC [Member] Segments [Axis] Segments [Axis] Prepaid expenses and other assets Increase (Decrease) in Prepaid Expense and Other Assets Work-in-process Inventory, Work in Process, Net of Reserves Payments for Endospan agreements Securities Purchase Option Agreement, Buyer Deposit Securities Purchase Option Agreement, Buyer Deposit Exercise Price Award Exercise Price Exchange Agreements Exchange Agreements [Member] Exchange Agreements Entity Filer Category Entity Filer Category Local Phone Number Local Phone Number Additional 402(v) Disclosure Additional 402(v) Disclosure [Text Block] Debt Instrument, net leverage ratio Debt Instrument, Net Leverage Ratio Debt Instrument, Net Leverage Ratio Inventory, Current [Table] Inventory, Current [Table] Other Adjustment to Reconcile Net Income to Cash Provided by (Used in) Operating Activity, Other Item Subsequent Event Type [Axis] Subsequent Event Type [Axis] Stock Compensation Share-Based Payment Arrangement [Text Block] Current portion of contingent consideration Business Combination, Contingent Consideration, Liability, Current Distribution fee Exclusive Distribution Agreement, Distribution Fee Exclusive Distribution Agreement, Distribution Fee Consideration for sale of assets Disposal Group, Including Discontinued Operation, Consideration ASSETS Assets [Abstract] Long-term debt, net Long-term debt, net Long-Term Debt, Excluding Current Maturities Credit Facility [Axis] Credit Facility [Axis] Underlying Security Market Price Change Underlying Security Market Price Change, Percent Debt Instrument [Axis] Debt Instrument [Axis] Financial Instruments Fair Value Disclosures [Text Block] Credit Facility [Domain] Credit Facility [Domain] Gross Carrying Value Finite-Lived Intangible Assets, Gross Stockholders’ equity: Equity, Attributable to Parent [Abstract] Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year [Member] Endospan Option Amendment Endospan Option Amendment [Member] Endospan Option Amendment Entity Address, Address Line One Entity Address, Address Line One Research and development Research and Development Expense Accumulated Other Comprehensive Loss AOCI Attributable to Parent [Member] Interest rate on amounts borrowed Debt Instrument, Interest Rate, Stated Percentage Schedule of Net Revenues by Product and Service Revenue from External Customers by Products and Services [Table Text Block] Non-current maturities of operating leases Operating Lease, Liability, Noncurrent Starch Medical Inc. Starch Medical Inc. [Member] Starch Medical, Inc. [Member] Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items] Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items] Fair Value as of Grant Date Award Grant Date Fair Value Entity Registrant Name Entity Registrant Name Stock Price or TSR Estimation Method Stock Price or TSR Estimation Method [Text Block] Customer lists and relationships Customer Lists [Member] Deferred compensation liability Deferred Compensation Liability, Classified, Noncurrent Funding of loan agreement per tranche Funding Of Loan Agreement Per Tranche Funding Of Loan Agreement Per Tranche EMEA Europe, the Middle East, and Africa Segments [Member] Europe, the Middle East, and Africa Segments Effect of dilutive stock options and awards (in shares) Incremental Common Shares Attributable to Dilutive Effect of Share-Based Payment Arrangements Authorized awards from approved stock incentive plans (in shares) Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Grants in Period Tranche Three Tranche Three [Member] Tranche Three Document Quarterly Report Document Quarterly Report Total assets Assets, Fair Value Disclosure Deferred income taxes Deferred Income Taxes and Tax Credits Changed Peer Group, Footnote Changed Peer Group, Footnote [Text Block] Counterparty Name [Domain] Counterparty Name [Domain] Preservation services Preservation Services [Member] Preservation Services [Member] Adjustment To PEO Compensation, Footnote Adjustment To PEO Compensation, Footnote [Text Block] Schedule of Short-Term and Long-Term Balances of Term Loan Schedule of Debt [Table Text Block] Title Trading Arrangement, Individual Title Peer Group Total Shareholder Return Amount Peer Group Total Shareholder Return Amount Schedule of Gross Carrying Values, Accumulated Amortization, and Approximate Amortization Period of Definite Lived Intangible Assets Schedule of Finite-Lived Intangible Assets [Table Text Block] Restatement Determination Date: Restatement Determination Date [Axis] Equity compensation Shares Issued, Value, Share-Based Payment Arrangement, after Forfeiture Non-PEO NEO Non-PEO NEO [Member] Employee stock purchase plan Stock Issued During Period, Value, Employee Stock Purchase Plan Delayed Draw Term Loan Facility Delayed Draw Term Loan Facility [Member] Delayed Draw Term Loan Facility Other Proceeds from (Payment for) Other Financing Activity Interest expense Interest Expense, Debt Contingent consideration receivable Disposal Group Including Discontinued Operation, Contingent Consideration Receivable Disposal Group Including Discontinued Operation, Contingent Consideration Receivable Other Other Intangible Assets [Member] Revolving Credit Facility Revolving Credit Facility1 [Member] Revolving Credit Facility1 Name Trading Arrangement, Individual Name Award Type [Domain] Award Type [Domain] Other comprehensive (loss) income: Statement of Other Comprehensive Income [Abstract] Equity Awards Adjustments Equity Awards Adjustments [Member] Pension Benefits Adjustments, Footnote Pension Benefits Adjustments, Footnote [Text Block] North America North America Segment [Member] North America Segment Disaggregation of Revenue [Line Items] Disaggregation of Revenue [Line Items] Compensation Amount Outstanding Recovery Compensation Amount Debt instrument, face amount Debt Instrument, Face Amount Debt Instrument, Name [Domain] Debt Instrument, Name [Domain] Endospan Loans Endospan Loans [Member] Endospan Loans Certificates of deposit Certificates of Deposit [Member] Recovery of Erroneously Awarded Compensation Disclosure [Line Items] Endospan Loan Endospan Loan [Member] Endospan Loan MNPI Disclosure Timed for Compensation Value MNPI Disclosure Timed for Compensation Value [Flag] Name Awards Close in Time to MNPI Disclosures, Individual Name Number of tranches Number Of Tranches Number Of Tranches Change in fair value of contingent consideration Change in fair value of contingent consideration Change in valuation Business Combination, Contingent Consideration, Change in Contingent Consideration, Liability, Increase (Decrease) Aggregate Erroneous Compensation Not Yet Determined Aggregate Erroneous Compensation Not Yet Determined [Text Block] ESPP Employee Stock [Member] Revenues: Revenues [Abstract] Variable Interest Entity, Primary Beneficiary, Does Not Hold Majority Voting Interest, Disclosures [Abstract] In-process R&D In Process Research and Development [Member] Accumulated other comprehensive loss Accumulated Other Comprehensive Income (Loss), Net of Tax Segment [Domain] Segments [Domain] Tranche One Tranche One [Member] Tranche One Aggregate Pension Adjustments Service Cost Aggregate Pension Adjustments Service Cost [Member] Fair Value Hierarchy [Domain] Fair Value Hierarchy and NAV [Domain] Inventories Inventories Inventory, Net Non-cash amortization of debt issuance costs Amortization of Debt Issuance Costs and Discounts Finite-Lived Intangible Assets by Major Class [Axis] Finite-Lived Intangible Assets by Major Class [Axis] Minimum Minimum [Member] Cost of products and preservation services: Cost of Revenue [Abstract] Company Selected Measure Name Company Selected Measure Name For Period from Second Quarter To Fourth Quarter of Fiscal Year 2024 For Period from Second Quarter To Fourth Quarter of Fiscal Year 2024 [Member] For Period from Second Quarter To Fourth Quarter of Fiscal Year 2024 Schedule of Amortization Expense Finite-Lived Intangible Assets Amortization Expense [Table Text Block] Debt Debt Disclosure [Text Block] Preferred stock $0.01 par value per share, 5,000 shares authorized, no shares issued Preferred Stock, Value, Issued Aggregate Available Trading Arrangement, Securities Aggregate Available Amount Accounts payable Accounts Payable, Current Stock Appreciation Rights (SARs) Stock Appreciation Rights (SARs) [Member] Net income (loss) allocated to common stockholders Net Income (Loss) Available to Common Stockholders, Diluted All Executive Categories All Executive Categories [Member] Finished goods Inventory, Finished Goods, Net of Reserves Common stock $0.01 par value per share, 75,000 shares authorized, 49,983 and 49,330 shares issued as of March 31, 2026 and December 31, 2025, respectively Common Stock, Value, Issued Net (income) loss allocated to participating securities Undistributed Earnings (Loss) Allocated to Participating Securities, Basic Goodwill [Roll Forward] Goodwill [Roll Forward] Commitments and Contingencies Commitments and Contingencies Disclosure [Text Block] Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Table] Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Table] Debt prepayment premium Debt Instrument, Prepayment Premium Debt Instrument, Prepayment Premium Diluted (in shares) Diluted weighted-average common shares outstanding Weighted Average Number of Shares Outstanding, Diluted Commitments and contingencies Commitments and Contingencies Upon Our Receipt of Premarket Approval Upon Our Receipt of Premarket Approval [Member] Upon Our Receipt of Premarket Approval Non-GAAP Measure Description Non-GAAP Measure Description [Text Block] Credit Facilities, Convertible Senior Notes and Old Credit Facilities Credit Facilities, Convertible Senior Notes and Old Credit Facilities [Member] Credit Facilities, Convertible Senior Notes and Old Credit Facilities Raw materials and supplies Inventory, Raw Materials and Supplies, Net of Reserves Business Combination [Axis] Business Combination [Axis] Term Loan Facility Loans Payable [Member] Entity Small Business Entity Small Business Percentage of outstanding equity acquired Business Combination, Voting Equity Interest Acquired, Percentage Income Tax Disclosure [Abstract] Income Tax Disclosure [Abstract] Document Transition Report Document Transition Report Basic income (loss) per common share Net Income (Loss) Available to Common Stockholders, Basic [Abstract] Underlying Securities Award Underlying Securities Amount JOTEC GmbH Jotec Gmbh [Member] JOTEC GmbH [Member] Equity Component [Domain] Equity Component [Domain] Document Period End Date Document Period End Date PEO Actually Paid Compensation Amount PEO Actually Paid Compensation Amount Income Taxes Income Tax Disclosure [Text Block] Awards Close in Time to MNPI Disclosures, Table Awards Close in Time to MNPI Disclosures [Table Text Block] Upfront Acquisition Purchase Price Upfront Acquisition Purchase Price [Member] Upfront Acquisition Purchase Price Revenue from Contract with Customer [Abstract] Revenue from Contract with Customer [Abstract] Endospan option Securities Purchase Option Agreement, Fair Value Disclosure Securities Purchase Option Agreement, Fair Value Disclosure Document Type Document Type Level 3 Fair Value, Inputs, Level 3 [Member] Income (Loss) Per Common Share Earnings Per Share [Text Block] Name Outstanding Recovery, Individual Name Product and Service [Axis] Product and Service [Axis] Business Combination, Contingent Consideration, Type [Domain] Business Combination, Contingent Consideration, Type [Domain] Proceeds from exercise of stock options and issuance of common stock Proceeds from Issuance of Common Stock Total revenues Total revenues Revenue from Contract with Customer, Excluding Assessed Tax All Individuals All Individuals [Member] Long-term Debt, Type [Domain] Long-Term Debt, Type [Domain] Fair Value Disclosures [Abstract] Fair Value Disclosures [Abstract] Receivables Increase (Decrease) in Receivables Capital expenditures Payments to Acquire Property, Plant, and Equipment Name Forgone Recovery, Individual Name Total current assets Assets, Current Statistical Measurement [Axis] Statistical Measurement [Axis] Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested [Member] Other receivables Other Receivables, Net, Current APAC Asia Pacific Segment [Member] Asia Pacific Segment Aggregate Erroneous Compensation Amount Aggregate Erroneous Compensation Amount ESPP, percentage of market price for eligible employees Share-Based Compensation Arrangement by Share-Based Payment Award, Purchase Price of Common Stock, Percent Foreign currency translation Goodwill, Foreign Currency Translation, Gain (Loss) Disposal Group Name [Axis] Disposal Group Name [Axis] Credit and Guaranty Agreement Credit and Guaranty Agreement [Member] Credit and Guaranty Agreement Peer Group Issuers, Footnote Peer Group Issuers, Footnote [Text Block] Net income (loss) allocated to common stockholders Net Income (Loss) Available to Common Stockholders, Basic Erroneous Compensation Analysis Erroneous Compensation Analysis [Text Block] Schedule of Finite-Lived Intangible Assets [Table] Intangible Asset, Finite-Lived [Table] Current liabilities: Liabilities, Current [Abstract] Line of Credit Facility [Line Items] Line of Credit Facility [Line Items] Geographical [Axis] Geographical [Axis] Exchange aggregate shares (In shares) Debt Conversion, Converted Instrument, Shares Issued Total operating expenses Operating Expenses Rule 10b5-1 Arrangement Terminated Rule 10b5-1 Arrangement Terminated [Flag] Level 1 Fair Value, Inputs, Level 1 [Member] Gain from sale of non-financial assets Gain (Loss) on Disposition of Assets New Delayed Draw Term Loan Facility New Delayed Draw Term Loan Facility [Member] New Delayed Draw Term Loan Facility Foreign currency transaction gain (loss) Gain (Loss), Foreign Currency Transaction, before Tax Diluted (in usd per share) Diluted income (loss) per common share (in usd per share) Earnings Per Share, Diluted Additional Endospan Loan Additional Endospan Loan [Member] Additional Endospan Loan Erroneously Awarded Compensation Recovery Erroneously Awarded Compensation Recovery [Table] Trade receivables, net Accounts Receivable, after Allowance for Credit Loss, Current Title of 12(b) Security Title of 12(b) Security Disposal Groups, Including Discontinued Operations [Table] Disposal Groups, Including Discontinued Operations [Table] Treasury stock at cost, shares (in shares) Beginning balance, treasury stock (in shares) Ending balance, treasury stock (in shares) Treasury Stock, Common, Shares Income (loss) per share Earnings Per Share [Abstract] Earnings Per Share [Abstract] Consolidation Items [Domain] Consolidation Items [Domain] Gross margin Total gross margin Gross Profit Products Products [Member] Products [Member] Existing Revolving Credit Facility Existing Revolving Credit Facility [Member] Existing Revolving Credit Facility Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items] Fair Value, Assets Measured on Recurring Basis, Unobservable Input Reconciliation [Line Items] After Entering into the Endospan Loan Amendment After Entering Into the Endospan Loan Amendment [Member] After Entering Into the Endospan Loan Amendment Award Timing Disclosures [Line Items] Net (income) loss allocated to participating securities Undistributed Earnings (Loss) Allocated to Participating Securities, Diluted Schedule of Inventories Schedule of Inventory, Current [Table Text Block] Total principal debt Secured term loan facility Long-Term Debt, Gross Accrued compensation Employee-related Liabilities, Current RSUs And PSUs Restricted Stock Units and Performance Stock Units [Member] Restricted Stock Units and Performance Stock Units Accrued procurement fees Accrued Procurement Fees Donated tissue is procured from deceased human donors by tissue banks and organ procurement organizations, which consign the tissue to the Company for processing, preservation, and distribution. The Company accrues estimated procurement fees due at the time tissues are received based on contractual agreements between the Company and the tissue banks and organ procurement organizations. Net income (loss) Net income (loss) Net income (loss) Net Income (Loss) Attributable to Parent Intersegment Eliminations Intersegment Eliminations [Member] Expiration Date Trading Arrangement Expiration Date Product Information [Line Items] Product Information [Line Items] Property and equipment, net Property, Plant and Equipment, Net Segment Reporting Information [Line Items] Segment Reporting Information [Line Items] Preferred stock, shares authorized (in shares) Preferred Stock, Shares Authorized Adoption Date Trading Arrangement Adoption Date Base Rate Base Rate [Member] Maximum amount of future consideration payment Business Combination, Contingent Consideration, Range of Outcomes, Maximum, Amount Compensation Actually Paid vs. Net Income Compensation Actually Paid vs. Net Income [Text Block] Entity Current Reporting Status Entity Current Reporting Status Awards Close in Time to MNPI Disclosures Awards Close in Time to MNPI Disclosures [Table] Proceeds from issuance of convertible debt Proceeds from Convertible Debt Operating income Operating Income (Loss) Consolidated Entities [Domain] Consolidated Entities [Domain] Retained deficit Retained Earnings (Accumulated Deficit) Statement of Financial Position [Abstract] Statement of Financial Position [Abstract] Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested [Member] Executive Category: Executive Category [Axis] Impairment of indefinite lived intangible assets Impairment of Intangible Assets, Indefinite-Lived (Excluding Goodwill) Current portion of finance lease obligations Finance Lease, Liability, Current Contingent Consideration Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Roll Forward] Current Fiscal Year End Date Current Fiscal Year End Date Acquired technology Technology-Based Intangible Assets [Member] Subsequent Event Type [Domain] Subsequent Event Type [Domain] Cash payment Debt Conversion, Converted Instrument, Amount Finite-Lived Intangible Assets, Major Class Name [Domain] Finite-Lived Intangible Assets, Major Class Name [Domain] Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table [Member] Aortic stent grafts Aortic Stent Grafts [Member] Aortic Stent Grafts [Member] Payments related to sale of non-financial assets Payments Related To Sale of Non-financial Assets Payments Related To Sale of Non-financial Assets Other expense (income), net Other Nonoperating Income (Expense) Statement [Table] Statement [Table] Payable Disposal Group, Including Discontinued Operation, Accounts Payable Adjustments to reconcile net income (loss) to net cash from operating activities: Adjustment to Reconcile Net Income to Cash Provided by (Used in) Operating Activity [Abstract] Surgical sealants Surgical Sealants [Member] Surgical Sealants [Member] Net cash flows from financing activities: Cash Provided by (Used in) Financing Activity, Including Discontinued Operation [Abstract] Equity Awards Adjustments, Excluding Value Reported in Compensation Table Equity Awards Adjustments, Excluding Value Reported in the Compensation Table [Member] Other Other Products [Member] Other Products [Member] Variable Rate [Domain] Variable Rate [Domain] Non-current finance lease obligations Finance Lease, Liability, Noncurrent All Adjustments to Compensation All Adjustments to Compensation [Member] Fair Value, by Balance Sheet Grouping [Table] Fair Value, by Balance Sheet Grouping [Table] Amendment Flag Amendment Flag Inventories and deferred preservation costs Increase (Decrease) in Deferred Preservation Costs and Inventories The increase (decrease) during the reporting period in deferred preservation costs and inventories, associated with underlying transactions that are classified as operating activities. Preservation costs consists primarily of direct labor and materials and indirect costs which are deferred until revenue is recognized upon shipment of the tissue to an implanting facility. Treasury stock, at cost, 1,487 shares as of March 31, 2026 ‎and December 31, 2025 Treasury Stock, Common, Value Termination Date Trading Arrangement Termination Date Net cash flows provided by financing activities Cash Provided by (Used in) Financing Activity, Including Discontinued Operation Insider Trading Policies and Procedures Adopted Insider Trading Policies and Procedures Adopted [Flag] Measure: Measure [Axis] Basis of Presentation and Summary of Significant Accounting Policies Basis of Presentation and Significant Accounting Policies [Text Block] Basic (in shares) Basic weighted-average common shares outstanding (in shares) Weighted Average Number of Shares Outstanding, Basic Transfer Of Perclot Manufacturing Equipment Transfer Of Perclot Manufacturing Equipment [Member] Transfer Of PerClot Manufacturing Equipment [Member] Total cost of products and preservation services Cost of Product and Service Sold Schedule of Computation of Basic and Diluted Income (Loss) Per Common Share Schedule of Earnings Per Share, Basic and Diluted [Table Text Block] Segment Reporting [Abstract] Segment Reporting [Abstract] Pay vs Performance Disclosure, Table Pay vs Performance [Table Text Block] Current portion of contingent consideration Contingent Consideration, Current, Fair Value Contingent Consideration, Current, Fair Value Debt Disclosure [Abstract] Debt Disclosure [Abstract] Forgone Recovery due to Violation of Home Country Law, Amount Forgone Recovery due to Violation of Home Country Law, Amount Entity Tax Identification Number Entity Tax Identification Number Tranche Two Tranche Two [Member] Tranche Two Contingent Payment Upon PMA Approval Contingent Payment Upon PMA Approval [Member] Contingent Payment Upon PMA Approval Forgone Recovery due to Expense of Enforcement, Amount Forgone Recovery due to Expense of Enforcement, Amount Agreements with Endospan Distribution Agreement [Text Block] Distribution Agreement [Text Block] Consolidated Entities [Axis] Consolidated Entities [Axis] Share-based Compensation Arrangement by Share-based Payment Award [Line Items] Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] Common stock, par value (in dollars per share) Common Stock, Par or Stated Value Per Share Securities purchase option agreement, payment Securities Purchase Option Agreement, Option To Acquire Outstanding Securities, Payment Securities Purchase Option Agreement, Option To Acquire Outstanding Securities, Payment Common stock, shares issued (in shares) Common Stock, Shares, Issued Notes and loans receivable Disposal Group, Including Discontinued Operation, Accounts, Notes and Loans Receivable, Net Goodwill and Other Intangible Assets Goodwill and Intangible Assets Disclosure [Text Block] Change in valuation Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Settlements Baxter Achievement Of Worldwide Sales Baxter Achievement Of Worldwide Sales [Member] Baxter Achievement Of Worldwide Sales [Member] Schedule of Goodwill by Reportable Segment Schedule of Goodwill [Table Text Block] Interest expense Interest Expense, Nonoperating Trading Arrangement: Trading Arrangement [Axis] Total Shareholder Return Amount Total Shareholder Return Amount Other comprehensive income (loss), net of tax Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax Insider Trading Arrangements [Line Items] Security Exchange Name Security Exchange Name Total liabilities Liabilities Tranche One and Two Tranche One and Two [Member] Tranche One and Two Pension Adjustments Prior Service Cost Pension Adjustments Prior Service Cost [Member] Indefinite-lived Intangible Assets, Major Class Name [Domain] Indefinite-Lived Intangible Assets, Major Class Name [Domain] Operating expenses: Operating Expenses [Abstract] Material Terms of Trading Arrangement Material Terms of Trading Arrangement [Text Block] Other current liabilities Other Liabilities, Current Fair Value by Asset Class [Domain] Asset Class [Domain] Statement [Line Items] Statement [Line Items] Consolidation Items [Axis] Consolidation Items [Axis] Variable Rate [Axis] Variable Rate [Axis] Unamortized debt issuance costs Unamortized Debt Issuance Expense Rule 10b5-1 Arrangement Adopted Rule 10b5-1 Arrangement Adopted [Flag] Cash and cash equivalents Cash and Cash Equivalent LATAM Latin America Segment [Member] Latin America Segment Counterparty Name [Axis] Counterparty Name [Axis] Common Stock Common Stock [Member] Entity Incorporation, State or Country Code Entity Incorporation, State or Country Code Non-NEOs Non-NEOs [Member] Decrease in cash and cash equivalents Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Period Increase (Decrease), Including Exchange Rate Effect and Discontinued Operation